Barclays Maintains Overweight on Ovintiv, Raises Price Target to $80
Benzinga Newsdesk 2 days ago
Analyst RatingsNewsPrice Target
Barclays analyst Betty Jiang maintains Ovintiv (NYSE:OVV) with a Overweight and raises the price target from $75 to $80.
Barclays analyst Betty Jiang maintains Ovintiv (NYSE:OVV) with a Overweight and raises the price target from $75 to $80.